Loading…

Antiplasmodial activity of sesquilignans and sesquineolignans from Bonamia spectabilis

Phytochemical re-investigation of the aerial parts of Bonamia spectabilis (Convolvulaceae) led to the isolation of four minor tetrahydrofuran-type sesquilignans (bonaspectins E–H) together with the known neolignan virolongin A and the known lignan rel-(7 S,8 R,7′ R,8′ R)-3,3′,4,4′,5,5′-hexamethoxyli...

Full description

Saved in:
Bibliographic Details
Published in:Phytochemistry (Oxford) 2002-05, Vol.60 (2), p.167-173
Main Authors: Kraft, Carola, Jenett-Siems, Kristina, Köhler, Inga, Tofern-Reblin, Britta, Siems, Karsten, Bienzle, Ulrich, Eich, Eckart
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Phytochemical re-investigation of the aerial parts of Bonamia spectabilis (Convolvulaceae) led to the isolation of four minor tetrahydrofuran-type sesquilignans (bonaspectins E–H) together with the known neolignan virolongin A and the known lignan rel-(7 S,8 R,7′ R,8′ R)-3,3′,4,4′,5,5′-hexamethoxylignan. Their structures were established on the basis of spectral data. These six compounds as well as further seven lignanoids from B. spectabilis, characterised previously, were tested for their antiplasmodial activity against a chloroquine-sensitive strain (PoW) and a chloroquine-resistant clone (Dd2) of Plasmodium falciparum. Bonaspectin C 4″- O-glucoside, its aglycone, and bonaspectin D 4″- O-glucoside revealed the highest antiplasmodial activities (IC 50 values: 1.3, 2.0, 6.5 μM [PoW]; 1.7, 4.6, 3.7 μM [Dd2], respectively). Four minor tetrahydrofuran-type sesquilignans (bonaspectins E–H) together with virolongin A and rel-(7 S,8 R,7′ R,8′ R)-3,3′,4,4′,5,5′-hexamethoxylignan have been isolated from the aerial parts of Bonamia spectabilis (Convolvulaceae). These compounds as well as further lignanoids of this plant species were tested for their antiplasmodial activity in vitro.
ISSN:0031-9422
1873-3700
DOI:10.1016/S0031-9422(02)00101-2